1-3 of 3
Shanshan Chen, MD
Close
Sort by
Journal Articles

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Yuankai Shi, MD PhD, Bo Jia, Xiaohui He, MD, Youwu Shi, Mei Dong, MD, Jianliang Yang, MD, Liqiang Zhou, MD, Shengyu Zhou, MD, Peng Liu, MD, Yan Qin, MD, Sheng Yang, MD, Hua Lin, MD, Lin Gui, MD, Changgong Zhang, MD, Lin Wang, MD, Shanshan Chen, MD, Puyuan Xing, MD, Hongnan Mo, MD, Mingzhe Han, MD
Journal: Blood
Blood (2015) 126 (23): 2718.
https://doi.org/10.1182/blood.V126.23.2718.2718
Published: 2015
Journal Articles

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Hao Jiang, Daihong Liu, Lanping Xu, Kaiyan Liu, Shanshan Chen, MD, Bin Jiang, MD, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, MD, Xiaohui Zhang, Yazhen Qin, Yueyun Lai, Yanrong Liu, MD, PhD, Xiaojun Huang
Journal: Blood
Blood (2013) 122 (21): 4035.
https://doi.org/10.1182/blood.V122.21.4035.4035
Published: 2013
Journal Articles

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Hao Jiang, MD, Xiaojun Huang, MD, PhD, Shanshan Chen, MD, Bin Jiang, Qian Jiang, PhD, Yazhen Qin, Yueyun Lai
Journal: Blood
Blood (2009) 114 (22): 4281.
https://doi.org/10.1182/blood.V114.22.4281.4281
Published: 2009